World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
52
Citations
9741
World Ranking
4064
National Ranking
356

Overview

Gareth Pryce is affiliated with Queen Mary University of London in the United Kingdom. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a significant focus on several specialized subfields. These include Pathology and Forensic Medicine, Immunology, Molecular Biology, Oncology, and Developmental Neuroscience.

The main topics in Gareth Pryce's work encompass Multiple Sclerosis Research Studies, Polyomavirus and related diseases, Neurogenesis and neuroplasticity mechanisms, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, Peripheral Neuropathies and Disorders, and Immunodeficiency and Autoimmune Disorders.

Pryce's publication record includes numerous contributions to various scientific journals. Frequent publication venues include Multiple Sclerosis and Related Disorders, bioRxiv (Cold Spring Harbor Laboratory), Clinical & Experimental Immunology, Acta Neuropathologica, and Frontiers in Immunology.

Some recent papers authored or coauthored by Pryce are:

  • COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases (2020), Clinical & Experimental Immunology
  • The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis (2020), Multiple Sclerosis and Related Disorders
  • Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis (2020), Acta Neuropathologica
  • The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies (2020), Frontiers in Immunology
  • The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination (2022), Multiple Sclerosis and Related Disorders

Pryce frequently collaborates with other researchers in related fields. Notable coauthors include David Baker, Gavin Giovannoni, Klaus Schmierer, Angray S. Kang, and Mónica Marta.

Best Publications

  • Cannabinoids control spasticity and tremor in a multiple sclerosis model.

    D Baker;G Pryce;J L Croxford;P Brown

  • IMMUNOHISTOCHEMICAL LOCALIZATION OF CANNABINOID TYPE 1 AND VANILLOID TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 RECEPTORS IN THE MOUSE BRAIN

    L. Cristino;L. de Petrocellis;G. Pryce;D. Baker

  • Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells.

    Katarzyna Maresz;Gareth Pryce;Gareth Pryce;Eugene D Ponomarev;Giovanni Marsicano

  • Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

    Gareth Pryce;Zubair Ahmed;Deborah J. R. Hankey;Samuel J. Jackson

  • In silico patent searching reveals a new cannabinoid receptor.

    David Baker;Gareth Pryce;Wayne L. Davies;C. Robin Hiley

  • Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis

    John Greenwood;Claire E. Walters;Gareth Pryce;Naheed Kanuga

  • Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis

    David Baker;Monica Marta;Gareth Pryce;Gavin Giovannoni

  • MicroRNA-155 negatively affects blood–brain barrier function during neuroinflammation

    Miguel Alejandro Lopez-Ramirez;Dongsheng Wu;Gareth Pryce;Julie E. Simpson

  • Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice

    Lynsey G. Bilsland;James R. T. Dick;Gareth Pryce;Stefania Petrosino

  • COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.

    D Baker;C A K Roberts;G Pryce;A S Kang

  • SV40 large T immortalised cell lines of the rat blood-brain and blood-retinal barriers retain their phenotypic and immunological characteristics

    J Greenwood;G Pryce;L Devine;D.K Male

  • Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors.

    G Pryce;D Baker

  • Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis

    J M Anderson;David Hampton;R Patani;G Pryce

  • Inhibition of Rho GTPases with Protein Prenyltransferase Inhibitors Prevents Leukocyte Recruitment to the Central Nervous System and Attenuates Clinical Signs of Disease in an Animal Model of Multiple Sclerosis

    Claire E. Walters;Gareth Pryce;Deborah J. R. Hankey;Said M. Sebti

  • Lymphocyte migration into brain modelled in vitro: Control by lymphocyte activation, cytokines, and antigen☆

    David Male;Gareth Pryce;Christopher Hughes;Peter Lantos

  • Antigen presentation in brain: MHC induction on brain endothelium and astrocytes compared.

    D. K. Male;G. Pryce;C. C. W. Hughes

  • Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.

    J. Ludovic Croxford;Gareth Pryce;Gareth Pryce;Samuel J. Jackson;Samuel J. Jackson;Catherine Ledent

  • Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis

    Justin Warne;Gareth Pryce;Gareth Pryce;Julia M. Hill;Xiao Shi

  • Suppression of Autoimmune Retinal Disease by Lovastatin Does Not Require Th2 Cytokine Induction

    ME Gegg;R Harry;D Hankey;H Zambarakji

  • Cannabinoid control of neuroinflammation related to multiple sclerosis

    D Baker;S J Jackson;G Pryce

  • Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation.

    S.J. Jackson;G. Pryce;L.T. Diemel;M.L. Cuzner

Frequent Co-Authors

David Baker
David Baker University of Washington
Gavin Giovannoni
Gavin Giovannoni Queen Mary University of London
Sandra Amor
Sandra Amor University of Amsterdam
John Greenwood
John Greenwood University College London
Roger G. Pertwee
Roger G. Pertwee University of Aberdeen
Catherine Ledent
Catherine Ledent Université Libre de Bruxelles
Bert A. 't Hart
Bert A. 't Hart University of Amsterdam
Siddharthan Chandran
Siddharthan Chandran University of Edinburgh
Javier Fernández-Ruiz
Javier Fernández-Ruiz Complutense University of Madrid
Robin J.M. Franklin
Robin J.M. Franklin University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career paths. Many professionals complement their knowledge with advanced nursing roles, often through an nurse practitioner accelerated program. These programs offer a fast track to becoming advanced practitioners, blending clinical expertise with immunological principles.

Candidates without a nursing background can still pursue critical healthcare roles by enrolling in online BSN programs for non nurses. These accessible options enable a smooth transition into nursing, which is closely connected with immunology-based patient care and research.

For those seeking quicker entry into nursing, 12-month accelerated nursing programs provide an intensive path to becoming a registered nurse. These programs are ideal for motivated learners aiming to deepen their immunology knowledge alongside practical nursing skills.

Alternatively, easy LPN programs to get into offer foundational nursing education with shorter durations, suitable for those interested in supportive healthcare roles. Such pathways can serve as stepping stones into specialized immunology-related careers.

Best Scientists Citing Gareth Pryce

Trending Scientists

Recently Published Articles